Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-AMI Trial
NCT07776288Phase 2Not yet recruiting
- Sponsor
- Universidad de Chile
- Start
- Sep 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid, acetylcysteine, deferoxamine in ST elevation myocardial infarction (STEMI), reperfusion injury (IRI), sponsored by Universidad de Chile. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ascorbic acidacetylcysteinedeferoxamine
03
Conditions
ST elevation myocardial infarction (STEMI)reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT07776288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776288.